• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Tumbles 300 Points; Tesla Shares Plunge After Q2 Results

    7/24/24 12:30:09 PM ET
    $AZTR
    $LW
    $NUWE
    $PIRS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Packaged Foods
    Consumer Staples
    Get the next $AZTR alert in real time by email

    U.S. stocks traded lower midway through trading, with the Nasdaq Composite dipping more than 500 points on Wednesday.

    The Dow traded down 0.76% to 40,052.02 while the NASDAQ fell 2.89% to 17,476.46. The S&P 500 also fell, dropping, 1.75% to 5,458.52.

    Check This Out: Jim Cramer Calls Axsome A ‘Double Or Nothing Stock,’ Says SAP Is ‘Incredible’

    Leading and Lagging Sectors

    Utilities shares jumped by 0.8% on Wednesday.

    In trading on Wednesday, consumer discretionary shares fell by 3%.

    Top Headline

    Tesla Inc (NASDAQ:TSLA) shares dipped more than 11% on Wednesday on the heels of the company's second-quarter financial results. The EV maker noted that it expects 2024 vehicle volume growth to be lower than in 2023.

    Tesla said second-quarter revenue increased 2% year-over-year to $25.5 billion, beating the consensus estimate of $24.73 billion, according to estimates from Benzinga Pro. The company reported adjusted earnings of 52 cents per share, missing analyst estimates of 62 cents per share.

    Equities Trading UP
                           

    • Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) shares shot up 79% to $14.20 after the company announced that the company entered into a definitive merger agreement with Palvella Therapeutics.
    • Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) got a boost, surging 33% to $0.5345 after licensing partner Pfizer’s Phase 3 AFFINE trial evaluating giroctocogene fitelparvovec met its primary endpoint.
    • PROG Holdings, Inc. (NYSE:PRG) shares were also up, gaining 21% to $41.89 after the company reported better-than-expected second-quarter financial results. Also, the company raised its FY24 guidance above estimates.

    Equities Trading DOWN

    • Azitra, Inc. (NYSE:AZTR) shares dropped 75% to $1.2550 after the company announced the pricing of a $10 million public offering of 6,665,000 common shares and Class A warrants at $1.50 per share.
    • Shares of Nuwellis, Inc. (NASDAQ:NUWE) were down 37% to $2.61 after the company announced the pricing of a $2 million public offering of 469,340 common shares at $4.24 a share.
    • Lamb Weston Holdings, Inc. (NYSE:LW) was down, falling 27% to $57.76 after the company reported worse-than-expected quarterly financial results. Also, the company issued its FY25 EPS guidance below estimates.

    Also Check This Out: Top 3 Tech And Telecom Stocks That Are Set To Fly In July

    Commodities

    In commodity news, oil traded up 0.1% to $77.07 while gold traded up 0.9% at $2,428.50.

    Silver traded up 0.7% to $29.525 on Wednesday, while copper fell 0.6% to $4.1350.

    Euro zone

    European shares were mostly lower today. The eurozone's STOXX 600 fell 0.52%, Germany's DAX fell 0.83% and France's CAC 40 fell 0.99%. Spain's IBEX 35 Index rose 0.02%, while London's FTSE 100 fell 0.07%.

    The HCOB Eurozone manufacturing PMI declined to 45.6 in July from 45.8 in June, while services PMI slipped to 51.9 from 52.8. The HCOB France composite PMI climbed to 49.5 in July from 48.8 in the prior month, while German composite PMI declined to 48.7 from 50.4.

    The S&P Global Flash UK manufacturing PMI rose to 51.8 in July from 50.9 in June, while services PMI rose to 52.4 in July from 52.1 in the previous month.

    Asia Pacific Markets

    Asian markets closed lower on Wednesday, with Japan's Nikkei 225 falling 1.11%, Hong Kong's Hang Seng Index falling 0.91%, China's Shanghai Composite Index declining 0.46% and India's S&P BSE Sensex declining 0.35%.

    The HSBC India Manufacturing PMI climbed to 58.5 in July from 58.3 the prior month, while services PMI rose to 61.1 in July from 60.5. The au Jibun Bank Flash Japan composite PMI rose to 52.6 in July versus a final reading of 49.7 in June.

    Economics

    • U.S. mortgage applications declined by 2.2% in the latest week, compared to a 3.9% gain in the prior period.
    • The S&P Global flash manufacturing PMI fell to 49.5 in July from 51.6 in June and compared to market estimates of 51.7.
    • The S&P Global composite PMI climbed to 55.0 in July from 54.8 in the prior month.
    • The U.S. trade deficit in goods shrank to $96.84 billion in June versus a $99.37 billion gap in the earlier month.
    • Building permits increased by 3.9% to an annual rate of 1.454 million in June.
    • U.S. new home sales declined 0.6% month-over-month to an annualized rate of 617,000 in June.
    • The EIA said crude oil inventories in the U.S. declined by 3.741 million barrels in the week ended July 19, compared to market estimates of a 2.05 million decline.

    Now Read This: Tesla To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday

    Get the next $AZTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AZTR
    $LW
    $NUWE
    $PIRS

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Tesla Inc.
    $TSLA
    1/12/2026$120.00 → $130.00Underweight
    Wells Fargo
    Tesla Inc.
    $TSLA
    1/2/2026$444.00 → $439.00Hold
    Truist
    Lamb Weston Holdings Inc.
    $LW
    12/22/2025Outperform → Neutral
    BNP Paribas Exane
    PROG Holdings Inc.
    $PRG
    12/16/2025$50.00Buy
    B. Riley Securities
    Tesla Inc.
    $TSLA
    12/8/2025$425.00Overweight → Equal-Weight
    Morgan Stanley
    PROG Holdings Inc.
    $PRG
    11/21/2025$31.00Sell → Neutral
    BTIG Research
    More analyst ratings

    $AZTR
    $LW
    $NUWE
    $PIRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tigress Financial resumed coverage on Tesla with a new price target

    Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00

    2/12/26 10:13:29 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Analyst reiterated coverage on Tesla with a new price target

    Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously

    1/30/26 8:00:23 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Wells Fargo reiterated coverage on Tesla with a new price target

    Wells Fargo reiterated coverage of Tesla with a rating of Underweight and set a new price target of $130.00 from $120.00 previously

    1/12/26 9:31:17 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $AZTR
    $LW
    $NUWE
    $PIRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Schultz Carisa

    3 - Nuwellis, Inc. (0001506492) (Issuer)

    2/12/26 4:15:30 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Field Katharyn

    3 - Nuwellis, Inc. (0001506492) (Issuer)

    2/11/26 3:35:38 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Grasso Mika

    3 - Nuwellis, Inc. (0001506492) (Issuer)

    2/11/26 3:31:30 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AZTR
    $LW
    $NUWE
    $PIRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chair Craps Jan Eli B bought $2,432,330 worth of shares (50,000 units at $48.65) and was granted 317,647 shares, increasing direct ownership by 147% to 617,647 units (SEC Form 4)

    4 - Lamb Weston Holdings, Inc. (0001679273) (Issuer)

    2/6/26 5:10:07 PM ET
    $LW
    Packaged Foods
    Consumer Staples

    CEO Musk Elon bought $999,959,042 worth of shares (2,568,732 units at $389.28) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    9/15/25 6:01:19 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Chief Financial Officer Garner Brian bought $101,255 worth of shares (3,500 units at $28.93), increasing direct ownership by 3% to 132,597 units (SEC Form 4)

    4 - PROG Holdings, Inc. (0001808834) (Issuer)

    5/14/25 4:40:00 PM ET
    $PRG
    Diversified Commercial Services
    Consumer Discretionary

    $AZTR
    $LW
    $NUWE
    $PIRS
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Announces Changes to Board of Directors

    MINNEAPOLIS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced the appointment of Katharyn Field and Mika Grasso to its board of directors, effective January 21, 2026. Ms. Field is the Chief Executive Officer of ISpecimen Inc., where she oversees performance improvement and the redevelopment of the proprietary software platform. Prior to serving as Chief Executive Officer she served as President, Chairman, and as an independent director. She has served as a director of LogProstyle since September 2024, as an Executive Director of Akanda Corporation since Ju

    1/23/26 4:40:27 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Scientists Pointing to Hidden Power Source That Could Reshape Future of AI

    This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement. AUSTIN, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- MiningNewsWire: Global electricity demand is reaching a pivotal turning point. The International Energy Agency (IEA) now projects that global data-center electricity use will almost double by 2030, with AI-focused facilities increasing their consumption more than four times over the same span — a trajectory pushing power grids in the United States, China, Europe, Southeast Asia and other regions to their limits. The bottleneck is no longer data throughput or semiconductor performance; the critical constraint has become electricity it

    12/3/25 8:30:00 AM ET
    $AMZN
    $AVGO
    $META
    Catalog/Specialty Distribution
    Consumer Discretionary
    Semiconductors
    Technology

    $AZTR
    $LW
    $NUWE
    $PIRS
    SEC Filings

    View All

    Amendment: Lamb Weston Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K/A - Lamb Weston Holdings, Inc. (0001679273) (Filer)

    2/20/26 4:21:38 PM ET
    $LW
    Packaged Foods
    Consumer Staples

    SEC Form 10-K filed by PROG Holdings Inc.

    10-K - PROG Holdings, Inc. (0001808834) (Filer)

    2/18/26 9:28:51 AM ET
    $PRG
    Diversified Commercial Services
    Consumer Discretionary

    PROG Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - PROG Holdings, Inc. (0001808834) (Filer)

    2/18/26 8:24:01 AM ET
    $PRG
    Diversified Commercial Services
    Consumer Discretionary

    $AZTR
    $LW
    $NUWE
    $PIRS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Azitra, Inc. to Present at BIO Investment & Growth Summit

    BRANFORD, Conn., Feb. 19, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it will present at the BIO Investment & Growth Summit taking place in Miami Beach, Florida, March 2-3, 2026. The presentation will highlight recent updates and progress in Azitra's pipeline, including ATR-12, currently in a Phase 1b clinical trial in adult patients with Netherton syndrome; ATR-04, being developed in a Phase 1/2 trial for the treatment of moderate to severe EG

    2/19/26 8:00:00 AM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PROG Holdings Reports Fourth Quarter 2025 Results

    Consolidated revenues from Continuing Operations of $574.6 million; Net earnings of $40.5 million Adjusted EBITDA from Continuing Operations of $61.5 million Diluted EPS from Continuing Operations of $0.49; Non-GAAP Diluted EPS from Continuing Operations of $0.74 Progressive Leasing GMV of $534 million, PROG Marketplace GMV up 187% Four Technologies grows GMV 126% PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Purchasing Power, Four Technologies and MoneyApp today announced financial results for the fourth quarter ended December 31, 2025. "Q4 and full-year 2025 were periods of disciplined execution that demonstrated the strength and re

    2/18/26 7:30:00 AM ET
    $PRG
    Diversified Commercial Services
    Consumer Discretionary

    KBRA Assigns Preliminary Ratings to Purchasing Power Funding 2026-A, LLC

    KBRA assigns preliminary ratings to five classes of notes issued by Purchasing Power Funding 2026-A, LLC ("PPWR 2026-A"), a $225.00 million consumer installment receivable ABS transaction. PPWR 2026-A is a revolving ABS securitization with an initial securitization value of approximately $256.1 million and is collateralized by a pool of retail installment sales contracts ("Receivables") originated by Purchasing Power, LLC (the "Company" or "Purchasing Power"). Founded in 2001, Purchasing Power is an Atlanta, GA-based provider of an organization-sponsored payroll purchase program. On January 2, 2026, the Company was acquired for approximately $420 million by PROG Holdings, Inc. (NYSE:PRG)

    2/11/26 1:22:00 PM ET
    $PRG
    Diversified Commercial Services
    Consumer Discretionary

    $AZTR
    $LW
    $NUWE
    $PIRS
    Financials

    Live finance-specific insights

    View All

    PROG Holdings Reports Fourth Quarter 2025 Results

    Consolidated revenues from Continuing Operations of $574.6 million; Net earnings of $40.5 million Adjusted EBITDA from Continuing Operations of $61.5 million Diluted EPS from Continuing Operations of $0.49; Non-GAAP Diluted EPS from Continuing Operations of $0.74 Progressive Leasing GMV of $534 million, PROG Marketplace GMV up 187% Four Technologies grows GMV 126% PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Purchasing Power, Four Technologies and MoneyApp today announced financial results for the fourth quarter ended December 31, 2025. "Q4 and full-year 2025 were periods of disciplined execution that demonstrated the strength and re

    2/18/26 7:30:00 AM ET
    $PRG
    Diversified Commercial Services
    Consumer Discretionary

    Lamb Weston Announces Leadership Changes to Accelerate Focus to Win Strategy and Drive Shareholder Value

    Jan Craps Brings Global Experience to the Newly Created Executive Chair Role; James D. Gray Appointed Chief Financial Officer Lamb Weston Holdings, Inc. (NYSE:LW) announced today two leadership appointments intended to accelerate growth and drive long-term shareholder value. Jan Craps Appointed Executive Chair The Lamb Weston board of directors has appointed Jan Craps executive chair, effective February 6, 2026. Jan brings deep international experience to the newly created role, including more than 20 years with Anheuser-Busch InBev, most recently as the CEO and Co-Chair of Budweiser Brewing Company APAC, and CEO APAC for Anheuser-Busch InBev. Jan has shaped emerging and complex marke

    2/4/26 9:00:00 AM ET
    $LW
    Packaged Foods
    Consumer Staples

    PROG Holdings, Inc. to Release Fourth Quarter 2025 Financial Results on February 18, 2026

    PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Purchasing Power, Four Technologies, and Build, is scheduled to release financial results for the fourth quarter of 2025 on Wednesday, February 18, 2026 prior to the market open. The Company has also scheduled a live webcast for February 18, 2026 at 8:30 A.M. ET to discuss its financial results for the fourth quarter of 2025. The webcast can be accessed via the below link, or through the Events & Presentations section of the PROG Holdings investor relations website, https://investor.progholdings.com. Webcast Link: https://edge.media-server.com/mmc/p/6r2ad2sv About PROG Holdings, Inc. PROG Holdings,

    1/28/26 2:30:00 PM ET
    $PRG
    Diversified Commercial Services
    Consumer Discretionary

    $AZTR
    $LW
    $NUWE
    $PIRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Pieris Pharmaceuticals Inc.

    SC 13G/A - PALVELLA THERAPEUTICS, INC. (0001583648) (Subject)

    12/17/24 5:42:35 PM ET
    $PIRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Azitra Inc

    SC 13G/A - Azitra, Inc. (0001701478) (Subject)

    11/14/24 12:56:51 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Azitra Inc

    SC 13G/A - Azitra, Inc. (0001701478) (Subject)

    11/14/24 12:18:21 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care